// App-Quantinova.ai

: Nintedanib Treatment for Elderly Patients with Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • Y. Ochi

Principal Investigators

  • M. Kato

  • S. Sasaki

  • T. Nakamura

  • T. Yamada

  • H. Ihara

  • F. Takahashi

  • K. Takahashi

Medical Centers

  • Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  • Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  • Juntendo University Urayasu Hospital, Chiba, Japan

  • Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  • Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  • Juntendo Univ, Tokyo 113-8421, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Dyspnea

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A